MedTrace Logo

Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment

NCT03424824 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2022-01-21

No results posted yet for this study

Summary

A Multisite Randomized Clinical Trial Evaluating BP1.3656 Vs Placebo For Alcohol Use Disorder Treatment.

Conditions

Interventions

DRUG

BP1.3656 low dose

Tablet, once daily oral administration at the low dose

DRUG

BP1.3656 intermediate dose

Tablet, once daily oral administration at the intermediate dose

DRUG

Placebo

Tablet, once daily oral administration

DRUG

BP1.3656 high dose

Tablet, once daily oral administration at the high dose

Sponsors & Collaborators

Principal Investigators

  • Evgeny Krupitsky, Pr · Leningrad Regional Narcology Dispensary, Russia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-09
Primary Completion
2021-11-24
Completion
2021-11-24

Countries

  • Bulgaria
  • France
  • Russia

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03424824 on ClinicalTrials.gov